Survivin expression and resistance to anticancer treatments: Perspectives for new therapeutic interventions

Drug Resistance Updates

Volumn 5, Issue 2, 2002, Pages 65-72

  Zaffaroni, Nadia ^a   Daidone, Maria Grazia ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Anticancer drugs; Antisense oligonucleotides; Apoptosis; Dominant negative mutants; Ionizing radiation; Ribozymes; Survivin

Indexed keywords

ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; CASPASE; CISPLATIN; ETOPOSIDE; PACLITAXEL; RIBOZYME; SURVIVIN; BIRC5 PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN; TUMOR PROTEIN;

APOPTOSIS; CANCER; CANCER RESISTANCE; GAMMA IRRADIATION; HUMAN; IMMUNOTHERAPY; IONIZING RADIATION; MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REVIEW; STRUCTURE ACTIVITY RELATION; TUMOR CELL; TUMOR GROWTH; ANIMAL; BIOSYNTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; METHODOLOGY; PHYSIOLOGY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS;

EID: 0036551756     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(02)00049-3     Document Type: Review

References (49)

1. The Bcl-2 protein family: Arbiters of cell survival
2. Xa receptor EPR-1
3. The molecular basis and potential role of survivin in cancer diagnosis and therapy
4. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer
5. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
6. Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting
7. Survivin as a radioresistance factor in pancreatic cancer
8. Does resistance to apoptosis affect clinical response to antitumor drugs?
9. Apoptosis: Mediator or mode of cell killing by anticancer agents?
10. Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis- and anchorage-dependent growth
11. Expression of the anti-apoptosis gene survivin correlates with taxol resistance in human ovarian cancer
12. Proteases to die for
13. IAP family proteins-suppressors of apoptosis
14. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function
15. Regulation of microtubule stability and mitotic progression by survivin
16. Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
17. Inhibition of melanoma tumor growth in vivo by survivin targeting
18. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of cerbB-2 and survivin genes
19. The biochemistry of apoptosis
20. Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit
21. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy
22. The role of caspase-8 in resistance to cancer chemotherapy
23. The cancer anti-apoptosis mouse survivin gene: Characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression
24. Control of apoptosis and mitotic spindle checkpoint by survivin
25. Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
26. Survivin-AEx3 and survivin-2B: Two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties
27. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting
28. Cancer gene therapy using a survivin mutant adenovirus
29. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
30. From bench to clinic with apoptosis-based therapeutic agents
31. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin
32. Control of apoptosis during angiogenesis by survivin expression in endothelial cells
33. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy
34. Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis
35. Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization
36. Dysregulation of apoptosis in cancer
37. Apoptosis-regulating proteins as targets for drug discovery
38. The survivin saga goes in vivo
39. Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients
40. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
41. Caspases: Intracellular signaling by proteolysis
42. Apoptosis is critical for drug response in vivo
43. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways
44. Urine detection of survivin and diagnosis of bladder cancer
45. Catalytic nucleic acids: From lab to applications
46. A role for survivin in chemoresistance of endothelial cells mediated by VEGF
47. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
48. Analysis of human transcriptomes
49. Transducing signals of life and death